Efficacy of hyperbaric oxygen combined with dual antiplatelet therapy in elderly patients with acute cerebral infarction and its impact on nerve factors | Canada Hyperbarics Skip to main content
Study Thromb J 2025

Efficacy of hyperbaric oxygen combined with dual antiplatelet therapy in elderly patients with acute cerebral infarction and its impact on nerve factors

Wang B, Yu K, Wang J, Li Y, Li M — Thromb J, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared standard dual antiplatelet therapy (DAPT) with DAPT plus hyperbaric oxygen therapy (HBOT) in 122 elderly patients with acute cerebral infarction, administering HBOT for 3 consecutive daily sessions.

What They Found

The group receiving HBOT combined with DAPT showed a higher total effective rate and improved daily living activities (higher Barthel Index scores) compared to the DAPT-only group. They also exhibited better neurological scores (lower NIHSS and CSS), reduced inflammation (lower MMP-9, IL-6, CRP), and improved blood flow.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study involved a relatively small number of patients and a short treatment duration of only three daily sessions.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 41063286
Year Published 2025
Journal Thromb J

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.